Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 23.80M | £ 54.30M | £ 8.40M | £ 4.20M | £ 40.40M |
Total Assets | £ 2.54B | £ 2.53B | £ 2.31B | £ 2.27B | £ 2.34B |
Total Debt | £ 361.50M | £ 339.30M | £ 353.40M | £ 336.90M | £ 443.50M |
Net Debt | £ 337.70M | £ 285.00M | £ 345.00M | £ 332.70M | £ 403.10M |
Total Liabilities | £ 1.01B | £ 1.03B | £ 1.09B | £ 1.09B | £ 1.21B |
Stockholders Equity | £ 1.52B | £ 1.51B | £ 1.21B | £ 1.18B | £ 1.13B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |